ACCESSIBILITY

24/7

Headlines

11:34

Jensen Huang: "Laws of physics" limit Nvidia’s chip ramp as AI demand surges

11:10

Elron Ventures cashes out IronScales stake for $26M as PSG increases its holding

09:26

"Platformization is the game changer": Palo Alto Networks Q1 beat reinforces multiyear growth strategy

09:07

As we did in cybersecurity, it's time to declare AI a national project and establish Israel's first AI capital

Buzz

Most popular

Daily

Weekly

Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months

Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers

Salesforce seals $1.9 billion cash deal to acquire cloud backup company Own

Prompt Security raises $18 million Series A to protect enterprises from GenAI risks

Salesforce to slash jobs at Own after $1.9B acquisition finalized

More news

Biomed

20 stories about Biomed

Somite.ai takes pre-seed to $10M as it eyes to become ‘the OpenAI of stem cell biology’

03.09.24|James Spiro

The company has received an extension of $4.8 million just six months after its initial raise for its novel cell replacement therapies.

Biomed company CartiHeal acquired by Smith & Nephew for up to $330 million

22.11.23|Meir Orbach

The Israeli firm, which develops a biocompatible, coral-based, off-the-shelf implant for damaged joints, will initially receive $180 million in cash and up to a further $150 million contingent on financial performance

Billionaire Steve Cohen leads $27.5 million investment in MediWound

05.02.23|Golan Hazani

Cohen's Point72 hedge fund invested $15 million in the round in what is believed to be the billionaire’s first investment in an Israeli company

Betalin Therapeutics receives EU equity investment for its alternative insulin therapy

21.07.21|James Spiro

The Biomed startup seeks to eliminate the need for insulin injections and glucose testing

מימין דוקטור יהושוע גלייטמן אבנר לושי ופרופסור שלמה נו

Shuki Gleitman's GIBF raising $300 million in China for second biotech fund

31.05.21|Golan Hazani

The Guangzhou Sino-Israel Biotech Investment Fund (GIBF) focuses on life science investments and cooperates with leading Guangzhou organizations to bring Israeli biotech firms to the massive Chinese metropolitan

Moderna’s resigning CMO says he achieved what he cared about

25.02.21|Sophie Shulman

Tal Zaks: I never imagined that I’d develop a vaccine for the worst pandemic of our times

Covid-19 was one of the biomed industry’s finest hours, says Israeli Silicon Valley veteran

15.12.20|Ron Friedman

Aya Jakobovits, a trailblazer in the biomed sector who is participating in J-Ventures’ annual investor’s conference, speaks of how the coronavirus vaccines showcased the depth of new technology

קרן אמון מימין ד"ר תומר ברקוביץ ד"ר יאיר שינדל טוד סון איציק דבש

Israel’s aMoon fund saw a 15-fold return on its investment in Seer

09.12.20|Sophie Shulman

aMoon invested in the U.S. biomed company when it was valued at $228 million- after a Nasdaq IPO, its value ballooned to $3.5 billion

Biomed at the focus of new Israel-UAE business cooperation

25.10.20|CTech

New cross-business initiative is led by Tel-Aviv based consultancy firm Kamir Strategy and UAE-based PR firm Cosmopole

IATI asks government to designate tech and biomed companies as essential industries

24.09.20|Hagar Ravet

Ahead of the second lockdown, tech umbrella group urges decision-makers to allow the industry to keep specialized facilities open

Pitango HealthTech Fund: Ittai Harel (left), Managing Partner; Maya Perl, Principal; Guy Ezekiel,

250 companies and $6.5 billion: An in-depth look at Israel’s healthtech industry

27.08.20|Maya Perl, Ittai Harel, Guy Ezekiel

Israeli healthcare startups are no longer relying solely on technology, clinical data, or IP to generate value. They are reinventing business models and elevating the industry.

בניין ה בורסה משכן חדש רחוב אחוזת בית תל אביב

Biomed Company CartiHeal Considers a Nasdaq IPO

26.02.20|Golan Hazani

The company is looking to raise between $60 million and $80 million according to a valuation of $300 million to $400 million and has already hired Credit Suisse and Jefferies for this purpose, according to two people familiar with the matter

Exalenz Bioscience Acquired for $49M

19.02.20|Golan Hazani

Israeli-born billionaire & biomed entrepreneur Mori Arkin sold his company for 6.10 NIS per share. Learn more on CTech!

Biomed Entrepreneur Mori Arkin Nearing Sale of Exalenz to a U.S. Company

19.02.20|Golan Hazani

Tel Aviv-listed Exalenz is not considered one of the serial entrepreneur’s great successes, having lost 73% of its valuation over the past five years. The current deal will see it sold at a premium of tens of percentages, according to one source

FIMI Makes $25 Million Private Placement in Biomed Company Kamada

22.01.20|Tzally Greenberg

Israel-based private equity fund FIMI became the largest shareholder in Nasdaq and Tel Aviv-listed Kamada in November

FIMI Becomes Biggest Shareholder in Biomed Company Kamada

24.11.19|Golan Hazani and Tzally Greenberg

Nasdaq and Tel Aviv-listed Kamada develops protein-based pharmaceuticals for genetic disorders, as well as rabies antibodies and a serum against snake bites

Biomed Company BiomX Merges With New York-Listed Chardan Healthcare

17.07.19|Meir Orbach

BiomX develops customized therapies for conditions such as acne and inflammatory bowel disease

Pi Therapeutics Raises $19.7 Million

29.05.19|Hagar Ravet

Pi Therapeutics develops novel modulators of protein degradation for the treatment of cancer

Three Portfolio Companies of Len Blavatnik's Clal Biotechnology Raise Cash in One Week

04.07.18|CTech

Clal Biotechnology Industries is an Israel-based life sciences investment company

Fourth Time’s the Charm for Entera Bio IPO

01.07.18|Dror Reich

The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each